Covered recipient · General Payments record
LINDSEY ANN ROESSLER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,813.60
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $706.36 | 34 |
| Education | $79.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $182.35 | 7 |
| ABBVIE INC. | $136.27 | 8 |
| DePuy Synthes Sales Inc. | $122.67 | 1 |
| UCB, Inc. | $112.77 | 6 |
| Amgen Inc. | $80.91 | 5 |
| Ferring Pharmaceuticals Inc. | $62.64 | 3 |
| PFIZER INC. | $51.07 | 3 |
| GENZYME CORPORATION | $22.99 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.00 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105601 | CMS |
| ABBVIE INC. | $18.97 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105603 | CMS |
| ABBVIE INC. | $16.52 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105605 | CMS |
| ABBVIE INC. | $18.99 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105607 | CMS |
| ABBVIE INC. | $16.89 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105609 | CMS |
| ABBVIE INC. | $12.05 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105611 | CMS |
| ABBVIE INC. | $17.85 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105613 | CMS |
| ABBVIE INC. | $19.00 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105615 | CMS |
| Amgen Inc. | $13.94 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117668989 | CMS |
| Amgen Inc. | $15.75 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117668991 | CMS |
| Amgen Inc. | $18.93 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117367487 | CMS |
| Amgen Inc. | $16.05 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117668993 | CMS |
| Amgen Inc. | $16.24 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117367485 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.69 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118188530 | CMS |
| DePuy Synthes Sales Inc. | $122.67 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077872628 | CMS |
| Ferring Pharmaceuticals Inc. | $20.83 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137542666 | CMS |
| Ferring Pharmaceuticals Inc. | $20.98 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137542670 | CMS |
| Ferring Pharmaceuticals Inc. | $20.83 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137542674 | CMS |
| GENZYME CORPORATION | $22.99 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139897548 | CMS |
| Janssen Biotech, Inc. | $22.10 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078357609 | CMS |
| Janssen Biotech, Inc. | $16.92 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078357620 | CMS |
| Janssen Biotech, Inc. | $79.00 | 05/14/2024 | Education | Undisputed | 01/23/2026 | 1078357616 | CMS |
| Janssen Biotech, Inc. | $10.96 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078357624 | CMS |
| Janssen Biotech, Inc. | $17.87 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078357600 | CMS |
| Janssen Biotech, Inc. | $18.86 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078357604 | CMS |
| Janssen Biotech, Inc. | $16.64 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078357612 | CMS |
| PFIZER INC. | $16.44 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130999935 | CMS |
| PFIZER INC. | $17.76 | 09/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131928856 | CMS |
| PFIZER INC. | $16.87 | 10/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132130382 | CMS |
| UCB, Inc. | $19.66 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143409327 | CMS |
| UCB, Inc. | $20.13 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143409331 | CMS |
| UCB, Inc. | $19.79 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143409335 | CMS |
| UCB, Inc. | $17.66 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143409339 | CMS |
| UCB, Inc. | $16.99 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143409344 | CMS |
| UCB, Inc. | $18.54 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143409348 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.